Antimicrobials have contributed a lot to improved human health and animal health, productivity and welfare. However, during the last decade, antimicrobial resistance (AMR) has been identified as a major global public health issue. The fact that the use of antimicrobials drives the development of resistance, the extensive use in the livestock sector of antibiotics, the sub-set of antimicrobials effective against bacteria, has come under scrutiny (WHO, 2015). The large amounts of antibiotics use in livestock are mainly attributable to various kinds of prophylactic use and use as growth promoters, mostly administered to groups of animals. Such practices are rare in human medicine. There are reports on how resistant bacteria from animals have infected humans (reviewed by Hoelzer et al., 2017).However, how frequent this is, or how much the livestock sector contributes to the overall prevalence of resistant bacteria in humans, is largely unknown. Even so, the ongoing emergence of antibiotic resistance also jeopardizes their efficacy in curing animals from bacterial infections that threaten their health, welfare and productivity (Bengtsson and Wierup, 2006).